Next Article in Journal
ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
Next Article in Special Issue
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials
Previous Article in Journal
Zein Nanoparticles Improve the Oral Bioavailability of Curcumin in Wistar Rats
Previous Article in Special Issue
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(3), 362; https://doi.org/10.3390/pharmaceutics13030362
Action Date Notes Link
article pdf uploaded. 9 March 2021 12:33 CET Version of Record https://www.mdpi.com/1999-4923/13/3/362/pdf-vor
article supplementary file uploaded. 9 March 2021 12:33 CET - https://www.mdpi.com/1999-4923/13/3/362#supplementary
article xml file uploaded 15 March 2021 08:17 CET Original file -
article xml uploaded. 15 March 2021 08:17 CET Update -
article pdf uploaded. 15 March 2021 08:17 CET Updated version of record https://www.mdpi.com/1999-4923/13/3/362/pdf-vor
article html file updated 15 March 2021 08:18 CET Original file -
article html file updated 15 March 2021 10:01 CET Update -
article xml file uploaded 16 March 2021 05:44 CET Update -
article xml uploaded. 16 March 2021 05:44 CET Update https://www.mdpi.com/1999-4923/13/3/362/xml
article pdf uploaded. 16 March 2021 05:44 CET Updated version of record https://www.mdpi.com/1999-4923/13/3/362/pdf
article html file updated 16 March 2021 05:45 CET Update -
article html file updated 25 July 2022 06:50 CEST Update https://www.mdpi.com/1999-4923/13/3/362/html
Back to TopTop